€390,00 excl. VAT
- “BRIEFING ON CART-T CELLS TRIALS”
CAR-T cells therapies are at the forefront of innovation in oncology. “BRIEFING ON CART-T CELLS TRIALS” provides you with an accurate overview to explore the latest trials in this hot and rapidly evolging field.
More than 20 diseases, mainly hematological cancers and solid tumors
47 trials and 33 sponsors in Asia, Europa and USA
More than 12 antigens targeted by clinical trials registered on Clinicaltrials.gov from 01/01/2017 to 01/10/2018
Breakdown by disease of CAR-T cell trials registered on Clinicaltrials.gov from 01/01/2017 to 01/10/2018:
Acute Lymphoblastic Leukemia (ALL), B Acute Lymphoblastic Leukemia (B – ALL), Acute Myeloid Leukemia, B-cell Lymphoma, Diffuse Large B-cell Lymphoma, Blastic Plasmacytoid Dendritic Cell Neoplasm, Chronic Lymphocytic Leukemia (CLL,) Colon Cancer Liver Metastasis, EGFR-positive Colorectal Cance,r Hematological Malignancies, Leukemias, Lymphomas Hepatocellular Carcinoma, Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma Lymphoid Cancer, Multiple Myeloma ,Non Hodgkin Lymphoma, Pancreatic Cancer, Plasma Cell Myeloma, Solid Tumors, Systemic Lupus Erythematosus (SLE)